NCT07022158View on ClinicalTrials.gov

Antenatal Body Shape Index and Pregnancy Complications

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

April 1, 2024

Conditions
Gestational ComplicationsBody Mass IndexWaist CircumferenceGestational HypertensionGestational Diabetes Mellitus (GDM)Preeclampsia (PE)
Interventions
OTHER

The patients participating in the study were between 6 and 16 weeks of pregnancy. Height, body weight, and waist circumference were measured at the first antenatal visit at 2 weeks.

170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up.

Trial Locations (1)

14030

Abant Izzet Baysal University Faculty of Medicine, 14030, Bolu, Turkey, Bolu

All Listed Sponsors
lead

Abant Izzet Baysal University

OTHER

NCT07022158 - Antenatal Body Shape Index and Pregnancy Complications | Biotech Hunter | Biotech Hunter